Pending FDA regs
Executive Summary
According to FDA regulatory agenda published in Oct. 22 Federal Register, final NDA rewrite regs are scheduled for publication in December 1984; IND rewrite is scheduled for March 1985. Also scheduled for December publication is proposal for sulfiting agents in drugs and OTC exclusivity policy